Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.62M Hold
500,000
– – ﹤0.01% 3630
2026
Q1
$8.55M Buy
+500,000
New +$9.28M ﹤0.01% 3196
2024
Q2
– Sell
-801,000
Closed -$6.15M – 5967
2024
Q1
$6.15M Buy
801,000
+501,000
+167% +$4.86M ﹤0.01% 2905
2023
Q4
$4.38M Buy
300,000
+20,400
+7% +$324K ﹤0.01% 3279
2023
Q3
$5.13M Sell
279,600
-1,254,300
-82% -$21.3M ﹤0.01% 2955
2023
Q2
$20.6M Buy
1,533,900
+797,400
+108% +$7.85M ﹤0.01% 1821
2023
Q1
$8.18M Sell
736,500
-708,200
-49% -$6.85M ﹤0.01% 2617
2022
Q4
$14.4M Buy
+1,444,700
New +$13M ﹤0.01% 2246
2022
Q1
– Sell
-294,500
Closed -$14.8M – 6946
2021
Q4
$14.8M Buy
294,500
+218,000
+285% +$9.83M ﹤0.01% 2405
2021
Q3
$2.72M Sell
76,500
-300,000
-80% -$11.9M ﹤0.01% 3911
2021
Q2
$16.7M Buy
376,500
+326,600
+655% +$11.1M ﹤0.01% 2219
2021
Q1
$1.82M Buy
49,900
+19,900
+66% +$827K ﹤0.01% 4088
2020
Q4
$1.28M Buy
+30,000
New +$1.1M ﹤0.01% 4037

Other funds holding XPEV

Goldman Sachs's XPEV Position: Q2 2026 in Review

Goldman Sachs reduced its XPeng (XPEV) stake by 71% in Q2 2026, selling an estimated $88.2M and leaving 2,272,316 shares worth $30.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Goldman Sachs first reported a position in XPEV in Q3 2020 and has held it in 24 quarters since. The position peaked at $198M in Q3 2021. 221 funds tracked by Wall St. Rank hold XPEV as of Q2 2026.

  • Goldman Sachs held 2,272,316 shares of XPeng worth $30.1M as of Q2 2026.
  • Goldman Sachs sold 5,564,850 XPeng shares in Q2 2026, an estimated $88.2M.
  • XPeng made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2252 holding.
  • Goldman Sachs first reported a position in XPeng in Q3 2020 and has held it in 24 quarters since.
  • Goldman Sachs's XPeng position peaked at $198M in Q3 2021.
  • 221 funds tracked by Wall St. Rank held XPeng as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.